LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 254 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 10.51 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $446,000 | +4.4% | 3,400 | +21.4% | 0.02% | -11.8% |
| Q1 2021 | $427,000 | +53.6% | 2,800 | 0.0% | 0.02% | +41.7% |
| Q4 2020 | $278,000 | -11.7% | 2,800 | -15.2% | 0.01% | -20.0% |
| Q3 2020 | $315,000 | -27.8% | 3,300 | -15.4% | 0.02% | -28.6% |
| Q2 2020 | $436,000 | +53.5% | 3,900 | 0.0% | 0.02% | +23.5% |
| Q1 2020 | $284,000 | -22.2% | 3,900 | +11.4% | 0.02% | +13.3% |
| Q4 2019 | $365,000 | +4.9% | 3,500 | 0.0% | 0.02% | -6.2% |
| Q3 2019 | $348,000 | -13.0% | 3,500 | 0.0% | 0.02% | -5.9% |
| Q2 2019 | $400,000 | -26.1% | 3,500 | -18.6% | 0.02% | -26.1% |
| Q1 2019 | $541,000 | -7.4% | 4,300 | 0.0% | 0.02% | -17.9% |
| Q4 2018 | $584,000 | – | 4,300 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KNOTT DAVID M | 353,041 | $25,673,000 | 16.20% |
| Stonepine Capital Management, LLC | 160,919 | $11,702,000 | 12.38% |
| VILLERE ST DENIS J & CO LLC | 635,758 | $46,232,000 | 3.94% |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 982,049 | $71,415,000 | 3.51% |
| Elk Creek Partners, LLC | 246,251 | $17,907,000 | 3.08% |
| Tygh Capital Management, Inc. | 151,792 | $11,038,000 | 2.47% |
| Roubaix Capital, LLC | 20,034 | $1,457,000 | 2.21% |
| Conestoga Capital Advisors, LLC | 648,603 | $47,166,000 | 1.38% |
| RICE HALL JAMES & ASSOCIATES, LLC | 338,376 | $24,607,000 | 1.38% |
| Ikarian Capital, LLC | 200,000 | $14,544,000 | 1.09% |